15 - 16 January 2020, London, UK.
SMi are pleased to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London. As Europe's leading Pre-Filled Syringes conference, the 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment.

19 - 20 February 2020, London, UK.
Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.

4 - 5 February 2020, London, UK.
SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London. As the only B2B parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

19 - 20 February 2020, London, UK.
The field of RNA therapeutics is rapidly expanding, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.

5 - 7 November 2019, Frankfurt, Germany.
CPhI Worldwide, organised by Informa PLC, announced the winners of the prestigious 2019 CPhI Pharma Awards - celebrating the industry's top innovators, performers and outstanding achievements across 13 categories, spanning the entire industry supply chain. The winners have been recognised for delivering excellence in pharma and were unveiled during a ceremony on the opening evening of CPhI Worldwide in Frankfurt.

5 - 7 November 2019, Frankfurt, Germany.
CPhI Worldwide - the world's largest pharma event, taking place in Frankfurt, Germany - released the second part of its annual report focussed on biologicals.

Fittingly, in 2019 BioProduction - which features five concurrent streams of content covering the entire spectrum of biopharmaceutical development and production - will run alongside CPhI Worldwide for the first time, bringing together the entire pharma and biopharma supply chain.

20 - 21 January 2020, London, UK.
Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.